{"id":124043,"date":"2021-12-15T15:10:21","date_gmt":"2021-12-15T15:10:21","guid":{"rendered":"https:\/\/fin2me.com\/?p=124043"},"modified":"2021-12-15T15:10:21","modified_gmt":"2021-12-15T15:10:21","slug":"cathie-woods-ark-invest-buys-over-750000-shares-of-ginkgo-bioworks","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/cathie-woods-ark-invest-buys-over-750000-shares-of-ginkgo-bioworks\/","title":{"rendered":"Cathie Wood’s ARK Invest Buys Over 750,000 Shares of Ginkgo Bioworks"},"content":{"rendered":"
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Tuesday. Specifically, this fund bought roughly $7.3 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of this fund was down slightly on Tuesday.<\/p>\n
ARK Innovation ETF (NYSEARCA: ARKK) bought 764,703 shares of Ginkgo Bioworks. At Tuesday\u2019s closing price, this would have valued the sale at roughly $7.3 million. Even though this is a small fraction of their total holdings, every little bit counts. The Innovation ETF is down over 23% in the past year.<\/p>\n
Check out all the ARK Invest purchases for Tuesday as well:<\/p>\n
Fund<\/th>\n | Ticker<\/th>\n | Name<\/th>\n | Shares<\/th>\n<\/tr>\n<\/thead>\n |
---|---|---|---|
ARKF<\/td>\n | TCSLI<\/td>\n | TCS GROUP<\/td>\n | 73,600<\/td>\n<\/tr>\n |
ARKF<\/td>\n | DSYSJ<\/td>\n | DISCOVERY<\/td>\n | 29,478<\/td>\n<\/tr>\n |
ARKG<\/td>\n | VCYT<\/td>\n | VERACYTE<\/td>\n | 45,700<\/td>\n<\/tr>\n |
ARKG<\/td>\n | SLGC<\/td>\n | SOMALOGIC<\/td>\n | 187,013<\/td>\n<\/tr>\n |
ARKG<\/td>\n | SDGR<\/td>\n | SCHRODINGER<\/td>\n | 12,216<\/td>\n<\/tr>\n |
ARKG<\/td>\n | QSI<\/td>\n | QUANTUM-SI<\/td>\n | 51,318<\/td>\n<\/tr>\n |
ARKG<\/td>\n | PSNL<\/td>\n | PERSONALIS<\/td>\n | 100,496<\/td>\n<\/tr>\n |
ARKG<\/td>\n | NTLA<\/td>\n | INTELLIA THERAPEUTICS<\/td>\n | 20,655<\/td>\n<\/tr>\n |
ARKG<\/td>\n | MASS<\/td>\n | 908 DEVICES<\/td>\n | 20,047<\/td>\n<\/tr>\n |
ARKG<\/td>\n | FATE<\/td>\n | FATE THERAPEUTICS<\/td>\n | 196,581<\/td>\n<\/tr>\n |
ARKG<\/td>\n | ACCD<\/td>\n | ACCOLADE<\/td>\n | 116,240<\/td>\n<\/tr>\n |
ARKG<\/td>\n | BLI<\/td>\n | BERKELEY LIGHTS<\/td>\n | 44,000<\/td>\n<\/tr>\n |
ARKK<\/td>\n | SSYS<\/td>\n | STRATASYS<\/td>\n | 72,471<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NVTA<\/td>\n | INVITAE<\/td>\n | 18,000<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NTLA<\/td>\n | INTELLIA THERAPEUTICS<\/td>\n | 8,433<\/td>\n<\/tr>\n |
ARKK<\/td>\n | MTLS<\/td>\n | MATERIALISE<\/td>\n | 32,775<\/td>\n<\/tr>\n |
ARKK<\/td>\n | DNA<\/td>\n | GINKGO BIOWORKS<\/td>\n | 764,703<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | XPEV<\/td>\n | XPENG<\/td>\n | 97,697<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | VUZI<\/td>\n | VUZIX<\/td>\n | 32,182<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | BLDE<\/td>\n | BLADE AIR MOBILITY<\/td>\n | 44,068<\/td>\n<\/tr>\n |
ARKW<\/td>\n | COIN<\/td>\n | COINBASE GLOBAL<\/td>\n | 11,761<\/td>\n<\/tr>\n |
ARKW<\/td>\n | EDR<\/td>\n | ENDEAVOR GROUP<\/td>\n | 177,885<\/td>\n<\/tr>\n |
ARKW<\/td>\n | VCYT<\/td>\n | VERACYTE<\/td>\n | 50,910<\/td>\n<\/tr>\n |
ARKW<\/td>\n | ROKU<\/td>\n | ROKU<\/td>\n | 7,188<\/td>\n<\/tr>\n |
ARKX<\/td>\n | AVAV<\/td>\n | AEROVIRONMENT<\/td>\n | 16,273<\/td>\n<\/tr>\n |
ARKX<\/td>\n | GRMN<\/td>\n | GARMIN<\/td>\n | 8,728<\/td>\n<\/tr>\n |
ARKX<\/td>\n | MYNA<\/td>\n | MYNARIC<\/td>\n | 4,707<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24\/7 Wall St.<\/p>\n \t\t\t<\/p>\n \t\t\t\tALSO READ: Why This Wall Street Firm Is Still Very Bullish on Semiconductors for 2022 \t\t\t\t |